Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stoke Therapeutics
Biotech
Former FDA deputy joins AI biotech's board—Chutes & Ladders
Former FDA deputy joins AI biotech’s board. Summit flags new CCO. Struggling Cargo jettisons assets and execs.
Darren Incorvaia
,
Zoey Becker
Mar 21, 2025 8:30am
Biogen pays Stoke $165M, bagging Dravet drug to fire up pipeline
Feb 18, 2025 9:28am
BMS vet answers Foghorn’s call for CBO—Chutes & Ladders
Sep 6, 2024 8:30am
Stoke's Dravet syndrome med released of partial clinical hold
Aug 7, 2024 8:54am
Stoke's shares up 90% as epilepsy drug cuts convulsive seizures
Mar 26, 2024 9:09am
Stoke shares drop 30% as Dravet drug posts high adverse events
Jul 25, 2023 11:49am
